Prices are updated after-hours

Nasdaq 2021 - 02 - 08

1Life Healthcare, Inc.

ONEM | $16.47 2.87% 8.5% 0

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (409.29% volume)
Earnings Calendar: 2023-05-03
Market Cap: $ 3,365,650,643
http://www.onemedical.com
Sec Filling | Patents | 1700 employees

1Life Healthcare, Inc. engages in the provision of healthcare membership services. It offers walk-in immunizations and lab services, behavioral health, women's health, men’s health, LGBTQ+ care, pediatrics, sports medicine, lifestyle, and wellbeing programs. The company was founded by Thomas H. Lee in July 25, 2002 and is headquartered in San Francisco, CA.

women health women behavioral health healthcare membership

add to watch list Paper trade email alert is off

Activision Blizzard, Inc

ATVI | $94.42 0.13% 7.3M

Consumer Durables

(0.0% 1d) (0.0% 1m) (8.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (157.69% volume)
Earnings Calendar: 2023-11-06
Market Cap: $ 74,289,497,374
http://www.activisionblizzard.com
Sec Filling | Patents | 9200 employees

Activision Blizzard, Inc. engages in the development and publication of interactive entertainment. It operates through the following segments: Activision Publishing, Blizzard Entertainment, and King Digital Entertainment. The Activision Publishing segment develops and publishes interactive software products and entertainment content, particularly for the console platform. The Blizzard Entertainment segment develops and publishes interactive software products and entertainment content, particularly for the PC platform. The King Digital Entertainment segment develops and publishes interactive entertainment content and services, particularly on mobile platforms, such as Google's Android and Apple's iOS. The company was founded in 1979 and is headquartered in Santa Monica, CA.

add to watch list Paper trade email alert is off

Aerie Pharmaceuticals, Inc.

AERI | $15.25 0.0%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (13.48% volume)
Earnings Calendar: 2023-02-23
Market Cap: $ 753,615,457
http://www.aeriepharma.com
Sec Filling | Patents | 380 employees

(US) Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.

eye treatment

Drugs

Rhopressa (netarsudil)
Rocklatan (netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

add to watch list Paper trade email alert is off

DISH Network Corporation

DISH | $5.77 -0.69% 51M

Consumer Services

(0.0% 1d) (-0.5% 1m) (-19.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 3,062,174,757
http://www.dish.com
Sec Filling | Patents | 16000 employees

(US) DISH Network Corp. is a holding company, which engages in the provision of pay-tv services. It operates through Pay-TV and Wireless segments. The Pay-TV segment operates under the DISH brand and Sling brand. The Wireless segment refers to the wireless spectrum licenses and related assets. The company was founded by Charles W. Ergen, Cantey W. Ergen and James DeFranco in 1980 and is headquartered in Englewood, CO.

brands

add to watch list Paper trade email alert is off

E.Merge Technology Acquisition Corp.

ETAC | $10.06

Finance

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (291.15% volume)
Earnings Calendar:
Market Cap: $ 615,672,000

Sec Filling | Patents | 2 employees

E.Merge Technology Acquisition Corp. operates as a blank check company which intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on May 22, 2020 and is headquartered in Burlingame, CA.

acquisitions msa blank check

add to watch list Paper trade email alert is off

Ebix, Inc.

EBIX | $1.16 -32.16% 0.0% 0

Finance

(0.0% 1d) (0.0% 1m) (-89.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-15.73% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 35,845,670
http://www.ebix.com
Sec Filling | Patents | 7975 employees

(US) Ebix, Inc. engages in the provision of software and e-commerce services to the insurance, finance, and healthcare industries. It operates through the following product and service channels: EbixCash Exchanges, Insurance Exchanges, and Risk Compliance Solutions. The EbixCash Exchanges channel offers money transfer, payment, and ticketing and travel services. The Insurance Exchanges channel includes software, setup, customization, transaction processing, maintenance, and hosting services. The Risk Compliance Solutions channel comprises of certificates of insurance and consulting services. The company was founded in 1976 and is headquartered in John Creek, GA.

insurance payment

add to watch list Paper trade email alert is off

Electrameccanica Vehicles Corp. Ltd.

SOLO | $0.2122 1.37% 440K

Consumer Durables

(0.0% 1d) (0.0% 1m) (-58.3% 1y) (-3.0% 2d) (-5.8% 3d) (0.0% 7d) (-48.95% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 25,356,938
http://www.electrameccanica.com
Sec Filling | Patents | 63 employees

Electrameccanica Vehicles Corp. engages in development and manufacture of electric vehicles. It operates through Electric Vehicles and Custom Build Vehicles segments. The Electric Vehicles segment develops and manufactures electric vehicles for mass markets. The Custom Build Vehicles segment offers high-end custom built vehicles. The company was founded by Jerry Kroll and Henry R. Reisner on February 16, 2015 and is headquartered in Vancouver, Canada.

vehicles eletric vehicle electric vehicles eletrical

add to watch list Paper trade email alert is off

Evelo Biosciences, Inc.

EVLO | $0.3165 -87.39% 710K

Health Technology

(0.0% 1d) (0.0% 1m) (-89.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-17.9% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 6,008,068
http://www.evelobio.com
Sec Filling | Patents | 98 employees

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.

cancer msa treatment

add to watch list Paper trade email alert is off

EVO Payments, Inc.

EVOP 4 | $33.99 0.38% 0.38% 0

Commercial Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.4% 3d) (0.0% 7d) (553.84% volume)
Earnings Calendar: 2023-05-03
Market Cap: $ 1,646,149,160
http://www.evopayments.com
Sec Filling | Patents | 2400 employees

EVO Payments, Inc. is a holding company, which provides payments technology and services. It offers payment and commerce solutions. It operates through the Americas and Europe geographical segments. The Americas segment is composed of the United States, Canada, and Mexico. The Europe segment includes operations in the Czech Republic, Germany, Ireland, Poland, Spain, and the United Kingdom, as well as supporting merchants in France, Austria, Italy, the Nordics, and other Central and Eastern European. The company was founded by Rafik R. Sidhom in 1989 and is headquartered in Atlanta, GA.

payment

add to watch list Paper trade email alert is off

BELLUS Health Inc.

BLU | $14.74 0.03% 0

Health Technology

(0.0% 1d) (0.0% 1m) (1.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (688.59% volume)
Earnings Calendar: 2023-08-09
Market Cap: $ 1,869,211,386
http://www.bellushealth.com
Sec Filling | Patents | 40 employees

(CA) BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

chronic cough hypersensitisation treatment

add to watch list Paper trade email alert is off

Casa Systems, Inc.

CASA | $0.055 -40.91% 65M

Electronic Technology

(0.0% 1d) (-82.6% 1m) (-95.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (17290.59% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 5,450,995
http://www.casa-systems.com
Sec Filling | Patents | 997 employees

(US) Casa Systems, Inc. engages in the provision and development of digital cable video and broadband services. Its products include cable, fixed, mobile, optical, and Wi-Fi networks; and casa access devices. The company was founded by Jerry Guo in 2003 and is headquartered in Andover, MA.

optical c-abl

add to watch list Paper trade email alert is off

CBM Bancorp, Inc.

CBMB | $17.71

Finance

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (43.58% volume)
Earnings Calendar:
Market Cap: $ 62,371,326
http://www.chesapeakebank.com
Sec Filling | Patents | 40 employees

CBM Bancorp, Inc. is a bank holding company, which engages in the provision of financial services. Its loan portfolio includes one-to four-family real estate loans, home equity loans and lines of credit, construction and land development, nonresident real estate loans, commercial loans, and consumer loans. The company was founded on May 22, 2018 and is headquartered in Baltimore, MD.

construction

add to watch list Paper trade email alert is off

Allena Pharmaceuticals, Inc.

ALNA | $0.075 -12.0%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (431.58% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 9,156,242
http://www.allenapharma.com
Sec Filling | Patents | 83 employees

(United States) Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company, which engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults; and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Newton, MA.

kidney diseases kidney stones treatment kidney

add to watch list Paper trade email alert is off

Altitude Acquisition Corp.

ALTU | $10.12 0.0% 69K

(0.0% 1d) (0.0% 1m) (0.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (7247.39% volume)
Earnings Calendar:
Market Cap: $ 89,406,607
https://altitudeac.com
Sec Filling | Patents | n/a employees

altitude acquisition corp. is blank check company newly incorporated as a delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. altitude intends to focus our efforts on identifying a prospective target business with either all or a substantial portion of its activities around the globe. we intend to focus on travel, travel technology and travel-related businesses with either business-to-business (“b2b”) or business-to-consumer (“b2c”) focuses, that have compelling growth opportunities with strong underlying demand drivers which include travel-related platforms including, but not limited to, travel booking engines; revenue, payment and expense management services; travel management companies; alternative accommodation and mobile-based travel solutions. we expect that these target companies will have characteristics appropriate for publi

travel

add to watch list Paper trade email alert is off

Amyris, Inc.

AMRS | $0.05 -21.88% -16.36% 47M

Process Industries

(0.0% 1d) (0.0% 1m) (-91.7% 1y) (0.0% 2d) (-19.5% 3d) (0.0% 7d) (46.83% volume)
Earnings Calendar: 2023-08-08
Market Cap: $ 18,469,281
http://www.amyris.com
Sec Filling | Patents | 561 employees

(US) Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Drugs

Squalane plus Mineral SPF 45 (Titanium Dioxide and Zinc Oxide)

add to watch list Paper trade email alert is off

Apollo Endosurgery, Inc.

APEN | $10.0 0.75% 1.7M

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-53.84% volume)
Earnings Calendar: 2023-05-02
Market Cap: $ 579,719,190
http://apolloendo.com
Sec Filling | Patents | 217 employees

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System, and Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders; esophageal stent fixation and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.

gastrointestinal endoscopy treatment

add to watch list Paper trade email alert is off

Applied Genetic Technologies Corporation

AGTC | News | $0.3936 1.23% 0.0%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-80.43% volume)
Earnings Calendar: 2022-11-08
Market Cap:
http://www.agtc.com
Sec Filling | Patents | 83 employees

(US) Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

gene therapies genetic clinical trials

add to watch list Paper trade email alert is off

Arco Platform Limited

ARCE | $13.99 -0.07% 470K

Technology Services

(0.0% 1d) (0.0% 1m) (23.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (151.94% volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 398,812,398
http://www.arcoeducacao.com.br
Sec Filling | Patents | 1423 employees

Arco Platform Ltd. is engaged in the provision of the educational services. It provides educational content in printed and digital format to the private schools. The firm operates through two segments: Core Curriculum and Supplemental Solutions. The Core Curriculum segment offers two versions, SAS & SAE for high income private schools and upper-middle income private schools respectively. The Supplemental Solutions segment comprises of proprietary applications, robotics and combination of concrete materials & animations. The company was founded by Ari de Sá Cavalcante Neto in 2004 and is headquartered in Consolação, Brazil.

education animals brasil

add to watch list Paper trade email alert is off

CDK Global, Inc.

CDK | $54.76 -0.15% 0.07%

Commercial Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1485.09% volume)
Earnings Calendar: 2022-08-17
Market Cap: $ 6,390,481,158
http://www.cdkglobal.com
Sec Filling | Patents | 9000 employees

(US) CDK Global, Inc. engages in the provision of integrated information technology and digital marketing solutions to the automotive retail industry. It operates through following segments: CDK North America and CDK International. The CDK North America segment provides technology-based solutions. The CDK International segment caters to the United States and Canada. The company was founded on September 30, 2014 and is headquartered in Hoffman Estates, IL.

automotive information technology digital marketing 3d

add to watch list Paper trade email alert is off

ChemoCentryx, Inc.

CCXI | News | $51.99 -0.04%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (160.14% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 3,709,791,785
http://www.chemocentryx.com
Sec Filling | Patents | 82 employees

(US) ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

cancer autoimmunity

add to watch list Paper trade email alert is off